Kambi Group plc (“Kambi”) has completed its first share buyback programme initiated on 19 June 2025 within the mandate approved at the Extraordinary General Meeting (EGM) on 18 June 2025 (the “Programme”). The second programme, also approved at the EGM on 18 June 2025, will run from 18 August to 21 November 2025.

The objective of the first Programme was to satisfy Kambi’s future obligations arising from its employee share option programmes. The Programme was carried out in accordance with the Maltese Companies Act, the EU Market Abuse Regulation No 596/2014 (MAR), Commission Delegated Regulation (EU) No 2016/1052 (Safe Harbour Regulation) and other applicable rules.

Kambi has during the period 14 August to 15 August 2025 (the “Buyback Period”) repurchased a total of 24,000 ordinary shares (ISIN: MT0000780107) as part of the share buyback programme at a volume-weighted average price of 139.29 SEK. From the beginning of the Programme, which started on 19 June, until and including 15 August 2025 Kambi has repurchased a total of 400,000 ordinary B shares at a volume-weighted average price of 137.31 SEK per share.

During the Buyback Period, Kambi has repurchased shares as follows:

Date
Aggregated daily volume (number of ordinary shares)
Weighted average share price per day (SEK)
Total daily transaction value (SEK)
14-Aug-2025
14,000
138.83
1,943,675
15-Aug-2025
12,000
139.82
1,677,828

All acquisitions have been carried out on Nasdaq First North Growth Market in Stockholm by DNB Carnegie Investment Bank AB on behalf of Kambi. Following the acquisitions and as of 15 August 2025, Kambi’s holding of its own shares amounted to 1,676,200 and the total number of issued shares in Kambi is 29,903,619 ordinary shares. Under the Programme Kambi was authorised to repurchase a maximum of 996,787 ordinary shares, up to a maximum amount of SEK 55 million (€5m).

A full breakdown of all transactions carried out during the Buyback Period is attached to this announcement.
Information on the Programme is available on Kambi’s website, https://www.kambi.com/investors/share-information/

For further information, please contact:

Mattias Frithiof
SVP Investor Relations & Sustainability
Mattias.Frithiof@kambi.com
Mobile: +46 73-599 45 77

About Kambi

Kambi Group is the home of premium sports betting services for licensed B2C gaming operators. Kambi’s portfolio of market-leading products include Turnkey Sportsbook, Odds Feed+, Managed Trading, Bet Builder, Esports, Front End and Sportsbook Platform. Kambi Group also operates esports data and odds supplier Abios, front end technology experts Shape Games and cutting-edge AI trading division Tzeract. Kambi Group’s partners include ATG, Bally’s Corporation, Corredor Empresarial, Kindred Group, LeoVegas, LiveScore, Rush Street Interactive and Svenska Spel. Kambi Group employs more than 1,000 staff across offices in Malta (headquarters), Australia, Denmark, Philippines, Romania, Sweden, the UK and the United States.

Kambi utilises a best of breed security approach and is ISO 27001 and eCOGRA certified. Kambi Group plc is listed on Nasdaq First North Growth Market under the symbol "KAMBI".

The Company's Certified Advisor is Redeye AB.

Attachments

Kambi completes first share buyback programme with second programme to run until November 21
Buyback Appendix 14 August – 15 August 2025

Läs mer på MFN

Ämnen i artikeln


Kambi Group

Senast

137,20

1 dag %

1,18%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.